10-Q: Arteris Inc. Reports First Quarter 2024 Results: Revenue Stable, Net Loss Persists
Quarterly Report
Arteris Inc. reported a stable revenue of $12.9 million for the first quarter of 2024, while experiencing a net loss of $9.4 million.
Summary
- Arteris Inc. reported a total revenue of $12.9 million for the three months ended March 31, 2024, a slight decrease from $13.1 million in the same period of 2023.
- The company's net loss for the quarter was $9.4 million, compared to a net loss of $9.0 million in the first quarter of 2023.
- Licensing, support, and maintenance revenue remained relatively flat at $11.7 million, while variable royalties decreased to $0.8 million from $1.3 million year-over-year.
- The company's operating expenses totaled $20.6 million, slightly down from $20.8 million in the prior year.
- Research and development expenses decreased by 5% to $10.8 million, while sales and marketing expenses increased by 9% to $5.5 million.
- The company's Annual Contract Value (ACV) was $53.5 million as of March 31, 2024, compared to $51.4 million in the prior year.
- Arteris had 21 Confirmed Design Starts during the quarter, compared to 22 in the same period of 2023.
- The remaining performance obligations (RPO) were $74.7 million as of March 31, 2024, up from $57.3 million in the prior year.
Sentiment
Score: 4
Explanation: The document presents a mixed picture. While revenue is stable and there's growth in ACV and RPO, the increasing net loss and decrease in royalties are concerning. The company faces significant risks and challenges, which temper the overall sentiment.
Positives
- The company's Annual Contract Value (ACV) increased to $53.5 million, indicating growth in customer adoption.
- Remaining Performance Obligations (RPO) increased to $74.7 million, suggesting future revenue growth.
- Operating expenses saw a slight decrease, indicating some cost control.
- The company's cash and cash equivalents increased to $26.1 million from $13.7 million at the end of 2023.
Negatives
- The company continues to experience net losses, with a $9.4 million loss in Q1 2024.
- Variable royalties decreased significantly, indicating a potential weakness in this revenue stream.
- The number of Confirmed Design Starts decreased slightly from 22 to 21 year-over-year.
- The company's accumulated deficit increased to $112.7 million.
Risks
- The company faces significant competition from larger companies and third-party providers.
- The semiconductor industry is cyclical and subject to rapid technological change.
- The company's revenue is dependent on market acceptance of third-party semiconductor IP.
- The company's international operations are subject to regulatory, operational, financial, and geopolitical risks.
- The company is subject to government regulations, including import, export, and economic sanctions laws.
- The company faces risks associated with doing business in China, including trade restrictions.
- The company is involved in ongoing patent litigation.
- The company's ability to raise capital in the future may be limited.
- The company's stock price may be volatile.
Future Outlook
The company expects to recognize $36.9 million of its remaining performance obligations over the next 12 months. The company anticipates research and development expenses will increase on an absolute basis and as a percentage of revenue in the near term, but decrease as a percentage of revenue in the medium to longer term. The company expects sales and marketing expenses to increase in absolute terms but decrease as a percentage of revenue. The company expects general and administrative expenses to increase as the business grows but decrease as a percentage of revenue over the long term.
Management Comments
- Management believes that the company's cash and cash equivalents, short-term investments, and cash provided by sales of products will be sufficient to meet expected working capital needs for at least the next 12 months.
- Management uses key performance indicators to analyze business performance and develop strategic plans.
Industry Context
The company operates in the semiconductor industry, which is characterized by rapid technological change, product obsolescence, competitive pricing pressures, and fluctuations in product supply and demand. The company's growth is driven by the increasing complexity of SoCs and the demand for advanced System IP solutions. The company competes with larger companies and third-party providers, and its success depends on market acceptance of third-party licensable IP.
Comparison to Industry Standards
- Arteris's performance is benchmarked against other semiconductor IP providers like Arm Limited, EXTOLL GmbH, Openedges Technologies Inc., Sdn. Bhd, Signature IP, SkyeChip, and TrueChip.
- The company's revenue is impacted by the cyclical nature of the semiconductor industry, similar to other companies in the sector.
- The company's reliance on a few key customers for a significant portion of its revenue is a common risk in the industry.
- The company's focus on new design wins and product launches is a typical strategy for growth in the semiconductor IP market.
- The company's investment in research and development is consistent with industry trends, but the company's ability to compete depends on its ability to innovate and improve its existing solutions.
Legal Proceedings
- The company is involved in ongoing patent litigation, which could have a material adverse effect on the company's business, financial position, results of operations, or cash flows.
Related Party Transactions
- The company has a lease agreement with Isabelle Geday, a member of the Board of Directors.
- The company has a consulting agreement with Ms. Geday, which was assigned to Magillem Design Services S.A.
- The company has a no-fee non-exclusive evaluation license agreement with Transchip Technology (Nanjing) Co., Ltd., an equity method investee.
Stakeholder Impact
- Shareholders may be concerned about the company's continued net losses and the potential impact on the stock price.
- Employees may be affected by the company's efforts to manage costs and improve efficiency.
- Customers may be impacted by the company's ability to provide high-quality support and innovative solutions.
- Suppliers may be affected by the company's financial performance and its ability to meet its obligations.
- Creditors may be concerned about the company's ability to repay its debts.
Next Steps
- The company will continue to invest in research and development.
- The company will continue to expand its sales force.
- The company will continue to evaluate growth opportunities through acquisitions.
Key Dates
| Date | Description |
|---|---|
| 2004-04-12 | Arteris, Inc. was incorporated in Delaware. |
| 2020-11 | The company entered into a lease agreement with Isabelle Geday, a member of the Board of Directors. |
| 2021-12-01 | The company signed a consulting agreement with Ms. Geday. |
| 2022-01-10 | The consulting agreement with Ms. Geday was assigned to Magillem Design Services S.A. |
| 2022-12 | The company received notice of a patent infringement complaint. |
| 2023-08 | Transchip began a no-fee evaluation of additional company products. |
| 2024-03-31 | End of the first quarter of 2024. |
| 2024-04-25 | Date of share count disclosure, with 38,479,122 shares of common stock outstanding. |
Keywords
semiconductor IP, interconnect, System-on-Chip, NoC, licensing, royalties, design starts, ACV, RPO, software, SIA, chiplets
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.